7 Best Peptides for Hearing Loss
People pursuing peptide options for hearing loss are working with one of the most challenging targets in regenerative research: cochlear hair cells do not regenerate once lost, and no peptide therapy has yet reached FDA approval for any form of hearing loss. A real and active research field exists nonetheless, and seven compounds have been studied, used, or discussed for this goal, ranging from D-JNKI-1, the most clinically advanced candidate that reached Phase 3 trials, to BPC-157, which has no hearing-specific trial data but appears consistently in community discussions. The compounds here are ordered by how prominently each appears in research and real-world use, not as a recommendation of one over another. The honest picture across all seven entries is that the evidence base is thin, and what varies is the degree of thinness, from a failed Phase 3 program to pure anecdote.
